Yes, promethazine is sometimes prescribed off-label for motion-induced nausea, but this use is not formally approved in the UK. A prescriber will weigh the benefits against potential side effects such as drowsiness.
Phenergan commonly causes drowsiness and can impair reaction time. Avoid driving or operating machinery until you know how the medication affects you, especially after the first dose.
The 10 mg tablet typically bears the imprint “PH 10” and the 25 mg tablet may show “PH 25”. Imprints can vary between manufacturers; verify with your pharmacist if in doubt.
Concurrent use of multiple antihistamines can increase anticholinergic and sedative effects. Discuss with a healthcare professional before combining them.
Promethazine crosses the placenta and is excreted in breast milk. It should be used during pregnancy only when clearly needed and after a risk-benefit discussion with a prescriber.
Sedation typically peaks within 1-2 hours after ingestion and may persist for 4-6 hours, depending on the dose and individual metabolism.
If you are taking a monoamine oxidase inhibitor (MAOI) or a drug that prolongs the QT interval, promethazine may increase the risk of adverse cardiac events. Inform your prescriber of all current medications.
If a dose is missed close to bedtime, it is usually better to skip it and resume the regular schedule the next day. Do not double the dose to “catch up”.
There are no specific food restrictions, but avoid alcohol as it can intensify drowsiness and respiratory depression.
Unused tablets should be returned to a pharmacy collection point or disposed of according to NHS medication waste guidelines to protect the environment and prevent accidental ingestion.
Phenergan is a brand-name medication that contains promethazine as its active ingredient. The drug is supplied as a pill in strengths of 10 mg and 25 mg. In the United Kingdom Phenergan is classified as a prescription-only medicine (POM) and is marketed by Janssen-Cilag under the supervision of the Medicines and Healthcare products Regulatory Agency (MHRA). Promethazine belongs to the allergy-relief therapeutic class and is also used for nausea, vomiting, and short-term sedation.
Promethazine is a first-generation antihistamine that works by blocking the H₁ histamine receptors in the central nervous system and peripheral tissues. By inhibiting these receptors, it reduces the effects of histamine-one of the primary mediators of allergic symptoms such as itching, sneezing, and runny nose.
In addition to its antihistamine activity, promethazine has anticholinergic and sedative properties. The anticholinergic effect contributes to drying of secretions, which can be helpful in treating motion-related nausea, while the sedative action results from central nervous system depression and is useful for pre-operative anxiety or short-term sleep aid.
These indications are approved by the MHRA for the UK market. The drug is generally prescribed for adults and for children older than two years when the benefit outweighs the risk.
Promethazine has been studied for a few off-label purposes, such as treatment of anxiety in the short term and as an adjunct in migraine therapy. These uses are not approved by the MHRA and should only be considered under close medical supervision with an individualized risk assessment.
Absolute contraindications
Relative contraindications
If you have any of these conditions, discuss alternative treatments with your healthcare provider.
These effects are generally mild and transient. Drinking plenty of water and avoiding sudden position changes can help.
If you are taking other medicines, herbal supplements, or over-the-counter products, inform your pharmacist or prescriber before starting Phenergan.
Standard adult dosing for allergy relief:
10 mg tablet: one tablet every 4-6 hours as needed.
25 mg tablet: one tablet every 6-8 hours as needed.
Do not exceed 100 mg per day without medical advice.
Special populations:
Elderly: start with the lowest effective dose (usually 10 mg) and assess tolerance.
Renal or hepatic impairment: dose may need reduction; follow prescriber guidance.
Children (≥2 years): dosing is weight-based, typically 0.5 mg/kg per dose, not exceeding adult maximum.
Administration: Swallow the tablet whole with a full glass of water. It may be taken with or without food; food can slightly delay absorption but does not alter effectiveness.
Missed dose: If you remember a missed dose and it is more than 4 hours since the scheduled time, take it now. If the next dose is due within a short interval, skip the missed dose-do not double-dose.
Overdose: Symptoms may include extreme drowsiness, confusion, fever, rapid heartbeat, and seizures. Call emergency services (999 in the UK) and provide the tablet strength(s) taken. Treatment is supportive; activated charcoal may be used, and physostigmine is an antidote for severe anticholinergic toxicity under medical supervision.
Discontinuation: Phenergan does not normally require tapering. However, abrupt cessation after prolonged high-dose use may cause rebound insomnia or agitation; discuss any planned discontinuation with your prescriber.
Regular follow-up with a healthcare professional ensures the medication remains appropriate and safe.
This article provides educational information about Phenergan and is not a substitute for professional medical advice. Treatment decisions, including the use of unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
